The importance of biomarkers and molecular profiling for cancer diagnosis and treatment continues to grow. As the science and knowledge around biomarkers expands, it is challenging for cancer care providers to adequately keep up with this rapidly evolving area; for practices, hospitals, and health systems to develop processes for integration of appropriate testing; and to efficiently implement molecular testing to improve patient care as information and innovation continue to accelerate.
Operational issues including insurance coverage, reimbursement, and insufficient protocols were among the common barriers to biomarker testing cited by respondents to ACCC's 2018 Trending Now in Cancer Care survey.
Through BiomarkerLIVE, ACCC seeks to raise awareness about biomarker testing and integration into the oncology care continuum, increase access to patient and provider education materials, educate the multidisciplinary care team, curate vetted and designated resources, and establish a strong network of advocacy and professional partners to help facilitate the integration of precision medicine into everyday practice.
Through this project ACCC intends to:
Presented at the 2020 ASCO Virtual Scientific Program
BiomarkerLIVE Project from the Association of Community Cancer Centers Supports Providers in Integration of Precision Medicine into Everyday Practice
April 29, 2020